Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 4:15 pm Sale | 2025-07-31 | 13G | BiomX Inc. PHGE | MORGAN STANLEY MS | 0 0.000% | -97,581![]() (Position Closed) | Filing History |
| 2025-08-05 3:15 pm Purchase | 2025-06-30 | 13G | BiomX Inc. PHGE | MORGAN STANLEY MS | 97,581 7.100% | 97,581![]() (New Position) | Filing History |
| 2025-06-23 5:08 pm Sale | 2025-06-18 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 14,534 1.000% | -79,559![]() (-84.55%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 131,274 9.990% | 36,845![]() (+39.02%) | Filing History |
| 2025-05-15 4:29 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Alyeska Investment Group, L.P. | 121,899 9.270% | 121,899![]() (New Position) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-04-21 | 13G | BiomX Inc. PHGE | Rodney Hodges | 103,705 7.600% | 103,705![]() (New Position) | Filing History |
| 2025-05-08 07:39 am Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Orin Hirschman | 82,471 6.300% | 82,471![]() (New Position) | Filing History |
| 2025-03-04 5:34 pm Sale | 2025-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 131,269 9.990% | -84,234![]() (-39.09%) | Filing History |
| 2025-03-03 7:04 pm Purchase | 2025-02-27 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 818,866 9.990% | 0![]() (+0.00%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 215,503 19.990% | 166,395![]() (+338.83%) | Filing History |
| 2024-11-13 5:30 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 94,428 9.990% | 94,428![]() (New Position) | Filing History |
| 2024-11-13 5:14 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 46,152 4.900% | 46,152![]() (New Position) | Filing History |
| 2024-11-04 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Burbank John Howard III | 26,853 2.900% | 26,853![]() (New Position) | Filing History |
| 2024-10-28 4:01 pm Purchase | 2024-09-30 | 13G | BIOMX INC UNIT 1 COM & 1 WT EX PHGEU | Rodney Hodges | 560,267 3.100% | 560,267![]() (New Position) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 94,093 9.990% | 27,894![]() (+42.14%) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 818,866 9.990% | 786,707![]() (+2446.35%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 32,158 8.750% | 0 (Unchanged) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 49,108 15.600% | 25,149![]() (+104.96%) | Filing History |
| 2024-03-25 3:35 pm Purchase | 2024-03-15 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 16,078 5.500% | 16,078![]() (New Position) | Filing History |
| 2024-03-22 5:44 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 32,158 11.060% | 32,158![]() (New Position) | Filing History |

